Tumours of Haematopoietic and Lymphoid Tissues: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | ||
==Mastocytosis== | ==Mastocytosis ([[Mastocytosis|Overview Page Link]])== | ||
*[[Cutaneous Mastocytosis]] | *[[Cutaneous Mastocytosis]] | ||
| Line 15: | Line 15: | ||
*[[Mast Cell Sarcoma]] | *[[Mast Cell Sarcoma]] | ||
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2== | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== | ||
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | ||
| Line 22: | Line 22: | ||
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | ||
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)== | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== | ||
*[[Chronic Myelomonocytic Leukemia (CMML)]] | *[[Chronic Myelomonocytic Leukemia (CMML)]] | ||